Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-11-20 Huang Jane CMO, Hematology Sale −1,000 $87.00 $87K 1,100
2017-11-16 Huang Jane CMO, Hematology Sale −600 $85.00 $51K 2,100
2017-11-15 OYLER JOHN Chief Executive Officer Sale −3,798 $79.16 $301K 411,313
2017-11-15 OYLER JOHN Chief Executive Officer Sale −62,170 $80.29 $5.0M 349,143
2017-11-15 OYLER JOHN Chief Executive Officer Sale −100 $80.84 $8K 349,043
2017-11-14 OYLER JOHN Chief Executive Officer Sale −39,328 $79.55 $3.1M 435,618
2017-11-14 OYLER JOHN Chief Executive Officer Sale −20,407 $80.10 $1.6M 415,211
2017-11-14 OYLER JOHN Chief Executive Officer Sale −100 $81.00 $8K 415,111
2017-11-13 OYLER JOHN Chief Executive Officer Sale −8,109 $82.67 $670K 491,891
2017-11-13 OYLER JOHN Chief Executive Officer Sale −16,845 $83.24 $1.4M 475,046
2017-11-13 OYLER JOHN Chief Executive Officer Sale −100 $84.04 $8K 474,946
2017-11-13 Peterson Amy C. CMO, Immuno-oncology Sale −2,400 $82.79 $199K 1,201
2017-11-13 Peterson Amy C. CMO, Immuno-oncology Sale −1,201 $83.31 $100K 0
2017-10-13 BAKER BROS. ADVISORS LP Director Other disposition −49,200 0
2017-10-13 BAKER BROS. ADVISORS LP Director Other acquisition +7,102 7,102
2017-10-13 BAKER BROS. ADVISORS LP Director Other acquisition +7,102 7,102
2017-09-27 OYLER JOHN Chief Executive Officer Grant or award +515,000 21,745,525
2017-09-27 OYLER JOHN Chief Executive Officer Grant or award · Share Option (Right to Buy) +935,000 935,000
2017-09-27 Wang Xiaodong Director Grant or award +410,000 12,935,393
2017-09-27 Wang Xiaodong Director Grant or award · Share Option (Right to Buy) +750,000 750,000

Page 116 of 123 · 2,455 trades